Anemia at Discharge From the PICU: A Bicenter Descriptive Study.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 28 6 2019
medline: 4 8 2020
entrez: 28 6 2019
Statut: ppublish

Résumé

To determine the prevalence and risk markers of anemia at PICU discharge. Bicenter retrospective cohort study. Two multidisciplinary French PICUs. All children admitted during a 5-year period, staying in the PICU for at least 2 days, and for whom a hemoglobin was available at PICU discharge. None. Patient, admission, and PICU stay characteristics were retrospectively collected in the electronic medical records of each participating PICU. Anemia was defined according to the World Health Organization criteria. Among the 3,170 patients included for analysis, 1,868 (58.9%) were anemic at discharge from PICU. The proportion of anemic children differed between age categories, whereas the median hemoglobin level did not exhibit significant variations according to age. After multivariate adjustment, anemia at PICU admission was the strongest predictor of anemia at PICU discharge, and the strength of this association varied according to age (interaction). Children anemic at PICU admission had a reduced risk of anemia at PICU discharge if transfused with RBCs during the PICU stay, if less than 6 months old, or if creatinine level at PICU admission was low. Children not anemic at PICU admission had an increased risk of anemia at PICU discharge if they were thrombocytopenic at PICU admission, if they had higher C-reactive protein levels, and if they received plasma transfusion, inotropic/vasopressor support, or mechanical ventilation during the PICU stay. Anemia is frequent after pediatric critical illness. Anemia status at PICU admission defines different subgroups of critically ill children with specific prevalence and risk markers of anemia at PICU discharge. Further studies are required to confirm our results, to better define anemia during pediatric critical illness, and to highlight the causes of post-PICU stay anemia, its course, and its association with post-PICU outcomes.

Identifiants

pubmed: 31246740
doi: 10.1097/PCC.0000000000002015
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e400-e409

Auteurs

Pierre Demaret (P)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, CHC, Liège, Belgium.
Université de Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France.

Frédéric V Valla (FV)

Pediatric Intensive Care Unit, Hôpital Universitaire Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.

Hélène Behal (H)

CHU Lille, Unité de Biostatistiques, F-59000 Lille, France.

Yanis Mimouni (Y)

EPICIME (Epidémiologie, Pharmacologie, Investigation Clinique, Information Médicale, Mère-Enfant), Clinical Investigation Center, Hospices Civils de Lyon, Lyon, France.

Jean-Benoît Baudelet (JB)

CHU Lille, Pediatric Intensive Care Unit, F-59000 Lille, France.

Oliver Karam (O)

Division of Pediatric Critical Care Medicine, Children's Hospital of Richmond at VCU, Richmond, VA.

Morgan Recher (M)

Université de Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France.
CHU Lille, Pediatric Intensive Care Unit, F-59000 Lille, France.

Alain Duhamel (A)

Université de Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France.
CHU Lille, Unité de Biostatistiques, F-59000 Lille, France.

Marisa Tucci (M)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, Sainte-Justine Hospital and Université de Montréal, Montreal, QC, Canada.

Etienne Javouhey (E)

Pediatric Intensive Care Unit, Hôpital Universitaire Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.

Stéphane Leteurtre (S)

Université de Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France.
CHU Lille, Pediatric Intensive Care Unit, F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH